Keywords: UK, NICE Novartis, Xolair

UK’s NICE reaffirms decision to deny use of Novartis’ asthma drug Xolair for children

Article | 13 August 2010

Print This

The UK’s drug use watchdog the National Institute for Health and Clinical Excellence (NICE), in a final appraisal document ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in